Xcell Biosciences is a next-generation development and manufacturing platform for enhanced cell therapy performance.
Xcell Biosciences has raised $1.4M in total funding. The most recent round was Undisclosed. The last funding was announced in December 2024.
Xcell Biosciences's investors include LabCorp, Casdin Capital, Dynamk Capital, Viking Global Investors, Nimble Ventures.
Xcell Biosciences is headquartered in San Francisco, United States.
Xcell Biosciences is a next-generation development and manufacturing platform for enhanced cell therapy performance.
Xcell Biosciences is at the Undisclosed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Xcell Biosciences — Funding & Investors." VCBacked, December 17, 2024, https://www.vcbacked.co/company/xcell-biosciences. Accessed September 30, 2026.
VCBacked. (2024). Xcell Biosciences — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/xcell-biosciences
{{cite web |title=Xcell Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/xcell-biosciences |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated